Correlation Between AbbVie and Mesoblast
Can any of the company-specific risk be diversified away by investing in both AbbVie and Mesoblast at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AbbVie and Mesoblast into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AbbVie Inc and Mesoblast, you can compare the effects of market volatilities on AbbVie and Mesoblast and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AbbVie with a short position of Mesoblast. Check out your portfolio center. Please also check ongoing floating volatility patterns of AbbVie and Mesoblast.
Diversification Opportunities for AbbVie and Mesoblast
Good diversification
The 3 months correlation between AbbVie and Mesoblast is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding AbbVie Inc and Mesoblast in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mesoblast and AbbVie is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AbbVie Inc are associated (or correlated) with Mesoblast. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mesoblast has no effect on the direction of AbbVie i.e., AbbVie and Mesoblast go up and down completely randomly.
Pair Corralation between AbbVie and Mesoblast
Given the investment horizon of 90 days AbbVie is expected to generate 12.34 times less return on investment than Mesoblast. But when comparing it to its historical volatility, AbbVie Inc is 5.16 times less risky than Mesoblast. It trades about 0.06 of its potential returns per unit of risk. Mesoblast is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest 183.00 in Mesoblast on November 9, 2024 and sell it today you would earn a total of 1,686 from holding Mesoblast or generate 921.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 99.25% |
| Values | Daily Returns |
AbbVie Inc vs. Mesoblast
Performance |
| Timeline |
| AbbVie Inc |
| Mesoblast |
AbbVie and Mesoblast Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AbbVie and Mesoblast
The main advantage of trading using opposite AbbVie and Mesoblast positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AbbVie position performs unexpectedly, Mesoblast can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mesoblast will offset losses from the drop in Mesoblast's long position.| AbbVie vs. Merck Company | AbbVie vs. Pfizer Inc | AbbVie vs. Eli Lilly and | AbbVie vs. Bristol Myers Squibb |
| Mesoblast vs. Aditxt Inc | Mesoblast vs. Lipocine | Mesoblast vs. Connect Biopharma Holdings | Mesoblast vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |